Drug Detail:Ketorolac (eent) (monograph) (Acular)
Drug Class:
Usual Adult Dose for Corneal Refractive Surgery
0.4% Ophthalmic Solution: Instill 1 drop in the operated eye(s) four times a day as needed for pain and burning/stinging for up to 4 days following corneal refractive surgery
Use: For the relief of ocular pain and burning/stinging following corneal refractive surgery
Usual Adult Dose for Postoperative Ocular Inflammation
0.45% Ophthalmic Solution: Instill 1 drop in the affected eye(s) twice a day beginning 1 day prior to cataract surgery, continuing on the day of surgery, and through the first 2 weeks of the postoperative period
0.5% Ophthalmic Solution: Instill 1 drop in the affected eye(s) four times a day beginning 24 hours after cataract surgery and continue through the first 2 weeks of the postoperative period
Use: For the treatment of pain and inflammation following cataract surgery
Usual Adult Dose for Seasonal Allergic Conjunctivitis
0.5% Ophthalmic Solution: Instill 1 drop in the affected eye(s) four times a day
Use: For the temporary relief of ocular itching due to seasonal allergic conjunctivitis
Usual Pediatric Dose for Corneal Refractive Surgery
3 years or older:
0.4% Ophthalmic Solution: Instill 1 drop in the operated eye(s) four times a day as needed for pain and burning/stinging for up to 4 days following corneal refractive surgery
Use: For the relief of ocular pain and burning/stinging following corneal refractive surgery
Usual Pediatric Dose for Postoperative Ocular Inflammation
2 years or older:
0.5% Ophthalmic Solution: Instill 1 drop in the affected eye(s) four times a day beginning 24 hours after cataract surgery and continue through the first 2 weeks of the postoperative period
Uses: For the treatment of pain and inflammation following cataract surgery
Usual Pediatric Dose for Seasonal Allergic Conjunctivitis
2 years or older:
0.5% Ophthalmic Solution: Instill 1 drop in the affected eye(s) four times a day for the relief of ocular itching
Use: For the temporary relief of ocular itching due to seasonal allergic conjunctivitis
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
0.4% Ophthalmic Solution: Safety and efficacy have not been established in patients younger than 3 years.
0.45% Ophthalmic Solution: Safety and efficacy have not been established in patients younger than 18 years.
0.5% Ophthalmic Solution: Safety and efficacy have not been established in patients younger than 2 years.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Storage requirements:
- Protect from light; store 0.45% vials in the pouch.
General:
- This drug may be administered in conjunction with other topical ophthalmic drugs such as alpha-agonists, beta-blockers, carbonic anhydrase inhibitors, cycloplegics, and mydriatics.
- If more than one topical ophthalmic drug is being used, each one should be administered at least 5 minutes apart.
Patient advice:
- Avoid allowing the tip of the bottle to contact the eye or surrounding structures to avoid contamination.
- Avoid wearing contact lenses when using this drug.
- To avoid cross-contamination, use 1 bottle for each eye following bilateral ocular surgery; the same bottle of topical eye drops should not be used for both eyes.
- Seek medical attention if you develop an intercurrent ocular condition (e.g., trauma or infection) or have ocular surgery.
- Slowed or delayed healing may occur while using this drug.